Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease.
Leber's hereditary optic neuropathy (LHON), the most frequent mitochondrial disorder, is mostly due to three mitochondrial DNA (mtDNA) mutations in respiratory chain complex I subunit genes: 3460/ND1, 11778/ND4 and 14484/ND6. Despite considerable clinical evidences, a genetic modifying role of the mtDNA haplogroup background in the clinical expression of LHON remains experimentally unproven. We investigated the effect of mtDNA haplogroups on the assembly of oxidative phosphorylation (OXPHOS) complexes in transmitochondrial hybrids (cybrids) harboring the three common LHON mutations. The steady-state levels of respiratory chain complexes appeared normal in mutant cybrids. However, an accumulation of low molecular weight subcomplexes suggested a complex I assembly/stability defect, which was further demonstrated by reversibly inhibiting mitochondrial protein translation with doxycycline. Our results showed differentially delayed assembly rates of respiratory chain complexes I, III and IV amongst mutants belonging to different mtDNA haplogroups, revealing that specific mtDNA polymorphisms may modify the pathogenic potential of LHON mutations by affecting the overall assembly kinetics of OXPHOS complexes.
Pello
Rosa
R
CIBERER-U723, Hospital Universitario 12 de Octubre, Madrid 28041, Spain.
Martín
Miguel A
MA
Carelli
Valerio
V
Nijtmans
Leo G
LG
Achilli
Alessandro
A
Pala
Maria
M
Torroni
Antonio
A
Gómez-Durán
Aurora
A
Ruiz-Pesini
Eduardo
E
Martinuzzi
Andrea
A
Smeitink
Jan A
JA
Arenas
Joaquín
J
Ugalde
Cristina
C
D002460:Cell Line; D045744:Cell Line, Tumor; D004272:DNA, Mitochondrial / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D004318:Doxycycline / Q000494:pharmacology; D004579:Electron Transport / Q000187:drug effects / Q000235:genetics; D042967:Electron Transport Complex I / Q000096:biosynthesis / Q000235:genetics; D014450:Electron Transport Complex III / Q000096:biosynthesis / Q000235:genetics; D003576:Electron Transport Complex IV / Q000096:biosynthesis / Q000235:genetics; D004795:Enzyme Stability / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007700:Kinetics; D008928:Mitochondria / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D008957:Models, Genetic; D008969:Molecular Sequence Data; D009245:NADH Dehydrogenase / Q000235:genetics; D029242:Optic Atrophy, Hereditary, Leber / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D021122:Protein Subunits / Q000235:genetics; D017422:Sequence Analysis, DNA
D004272:DNA, Mitochondrial; C098483:NADH dehydrogenase subunit 4; D021122:Protein Subunits; C507225:MT-ND6 protein, human; D009245:NADH Dehydrogenase; C515075:NADH dehydrogenase subunit 1, human; D003576:Electron Transport Complex IV; D042967:Electron Transport Complex I; D014450:Electron Transport Complex III; D004318:Doxycycline